Investor Intelligence
11 Mental Health Investors in Europe
European investors with demonstrated activity across mental-health care, digital therapeutics, neuropsychiatry and technology-enabled treatment.
- Mental Health
- Digital Therapeutics
- Neuropsychiatry
- Digital Health
- Europe
Mental-health investing in Europe spans two distinct markets: technology that expands access to care and therapeutics targeting psychiatric or neurological disease. The investor set therefore includes digital-health specialists, impact funds and life-sciences investors with direct neuropsychiatry exposure.
DealBio selected 11 investors with evidenced relevance to mental health in Europe, using current investor research, financing precedents and public verification where needed.

Azimut Libera Impresa
Italian investment platform backing growth and technology companies through specialist funds.
- Stage
- Series A
- Sector / Focus
- Mental health · Virtual care · Digital health
- Investment markets
- Italy
- Investor type
- Investment firm
X-Equity Venture Club
Italian venture investment club backing technology companies.
- Stage
- Series A
- Sector / Focus
- Mental health · Virtual care · Digital health
- Investment markets
- Italy
- Investor type
- Venture investment club
Serpentine Ventures
Swiss early-stage investor backing technology and science-driven startups.
- Stage
- Pre-seed
- Sector / Focus
- Mental health · Neurotechnology
- Investment markets
- Switzerland
- Investor type
- VC
Calm/Storm
European early-stage healthtech investor focused on health and wellbeing.
- Stage
- Pre-seed · Seed · Series A
- Sector / Focus
- Mental health · Digital health · Wellbeing
- Investment markets
- Europe
- Investor type
- VC
Carma Fund
European life-sciences investor backing therapeutics and healthcare innovation.
- Stage
- Seed
- Sector / Focus
- Mental health · Depression · CNS therapeutics
- Investment markets
- France · Germany · Sweden
- Investor type
- VC
TT Ventures
Early-stage venture investor backing technology companies across Europe and Turkey.
- Stage
- Seed
- Sector / Focus
- Mental health · Digital therapeutics · Digital health
- Investment markets
- Turkey · Europe
- Investor type
- Corporate VC
4impact
European impact VC investing in technology companies with measurable social outcomes.
- Stage
- Seed
- Sector / Focus
- Mental health · Digital health · Consumer health
- Investment markets
- Germany · Europe
- Investor type
- VC
Access Biotechnology
Life-sciences investment firm backing biotechnology and therapeutics companies.
- Stage
- Series A
- Sector / Focus
- Depression · CNS therapeutics · Small molecules
- Investment markets
- United Kingdom · Europe
- Investor type
- VC
Gateway Ventures
Austrian investor network and venture platform backing early-stage companies.
- Stage
- Seed · Series A
- Sector / Focus
- Neurotechnology · Digital health · Patient monitoring
- Investment markets
- Austria · Germany
- Investor type
- VC / Investor network
Moonfire Ventures
European early-stage venture firm using data-led sourcing to invest from pre-seed onward.
- Stage
- Pre-seed · Seed · Series A
- Sector / Focus
- Mental health · Digital health
- Investment markets
- United Kingdom · Europe
- Investor type
- VC
SICTIC
Swiss angel-investor network backing early-stage technology companies.
- Stage
- Seed · Series A
- Sector / Focus
- Mental health · Neurotechnology · Digital health
- Investment markets
- Switzerland · Europe
- Investor type
- Angel network
Methodology
DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.